| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |